Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Surgery bests TAVR in young patients | The top US hospitals for cardiology & heart surgery | Preventing AFib
Thursday, August 27, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Cardiac Surgery

Surgery outperforms TAVR in young heart patients, new data confirm

Researchers tracked data from nearly 10,000 patients 60 years old or younger who underwent SAVR or TAVR. Propensity score matching was used to focus on two groups of approximately 1,500 patients.

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

Surgery outperforms TAVR in young heart patients, new data confirm

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Researchers tracked data from nearly 10,000 patients 60 years old or younger who underwent SAVR or TAVR. Propensity score matching was used to focus on two groups of approximately 1,500 patients.
READ MORE >

The best hospitals in the United States for heart care

U.S. News & World Report has released its latest ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. There are similarities—and some key differences—between this year's list and last year's list.

READ MORE >
heart doctor cardiologist
Share on Twitter Share on Facebook Share on Linkedin

The best hospitals in the United States for heart care

Share on Twitter Share on Facebook Share on Linkedin
heart doctor cardiologist
U.S. News & World Report has released its latest ranking of the top U.S. hospitals for cardiology, heart surgery and vascular surgery. There are similarities—and some key differences—between this year's list and last year's list.
READ MORE >

HCM drug advances have been a breakthrough—but more invasive treatments are still vital

Some HCM experts are concerned about the potential loss of surgical and interventional expertise as procedural volumes decline.

READ MORE >
Srihari S. Naidu, MD, FACC, FAHA, MSCAI, director of cath labs and hypertrophic cardiomyopathy, Westchester Medical Center, explains concerns about the possible loss of expertise in surgical myectomy and interventional alcohol septal ablation as the procedure volumes to treat hypertrophic cardiomyopathy (HCM) due to the introduction of new drug therapies.
Share on Twitter Share on Facebook Share on Linkedin

HCM drug advances have been a breakthrough—but more invasive treatments are still vital

Share on Twitter Share on Facebook Share on Linkedin
Srihari S. Naidu, MD, FACC, FAHA, MSCAI, director of cath labs and hypertrophic cardiomyopathy, Westchester Medical Center, explains concerns about the possible loss of expertise in surgical myectomy and interventional alcohol septal ablation as the procedure volumes to treat hypertrophic cardiomyopathy (HCM) due to the introduction of new drug therapies.
Some HCM experts are concerned about the potential loss of surgical and interventional expertise as procedural volumes decline.
READ MORE >

Medtronic recalls thousands of cannulae due to risk of leaks

More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.

READ MORE >
fda medical device recall
Share on Twitter Share on Facebook Share on Linkedin

Medtronic recalls thousands of cannulae due to risk of leaks

Share on Twitter Share on Facebook Share on Linkedin
fda medical device recall
More than 50,000 devices are being recalled due to pinhole leaks associated with multiple risks. Customers should return any unused cannulae to Medtronic.
READ MORE >

New STS guideline tackles the prevention of AFib after cardiac surgery

Among the guideline's most significant changes is a Class I recommendation for prophylactic amiodarone.

READ MORE >
Subhasis Chatterjee, MD, FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Baylor St. Lukes, explains the new 2026 guidelines for management of new onset post-operative atrial fibrillation (AFib), which he spoke about at the American Association for Thoracic Surgery (AATS) 2026 annual meeting.
Share on Twitter Share on Facebook Share on Linkedin

New STS guideline tackles the prevention of AFib after cardiac surgery

Share on Twitter Share on Facebook Share on Linkedin
Subhasis Chatterjee, MD, FACS, FACC, FCCP, Associate Professor of Surgery, Director Thoracic Surgical ICU and ECMO Program, Baylor St. Lukes, explains the new 2026 guidelines for management of new onset post-operative atrial fibrillation (AFib), which he spoke about at the American Association for Thoracic Surgery (AATS) 2026 annual meeting.
Among the guideline's most significant changes is a Class I recommendation for prophylactic amiodarone.
READ MORE >

Custom blood vessel grafts in minutes? Harvard engineers share vision of the future

Researchers have developed a new way to craft custom synthetic vascular grafts for patients in need of immediate care. The technique has shown early potential to be a game-changer for cardiovascular care. 

READ MORE >
Bioengineers from Harvard have developed a new way to craft custom synthetic vascular grafts in a matter of a minutes. The group shared its findings in Advanced Materials, highlighting the potential to provide on-demand care for patients in need.
Share on Twitter Share on Facebook Share on Linkedin

Custom blood vessel grafts in minutes? Harvard engineers share vision of the future

Share on Twitter Share on Facebook Share on Linkedin
Bioengineers from Harvard have developed a new way to craft custom synthetic vascular grafts in a matter of a minutes. The group shared its findings in Advanced Materials, highlighting the potential to provide on-demand care for patients in need.
Researchers have developed a new way to craft custom synthetic vascular grafts for patients in need of immediate care. The technique has shown early potential to be a game-changer for cardiovascular care. 
READ MORE >

American College of Cardiology leader named CEO of Society of Thoracic Surgeons

Justine Varieur Turco held several leadership positions with the American College of Cardiology over the years. She is also a former Cardiovascular Business editor.

READ MORE >
Justine Turco Incoming CEO/Executive Director Society of Thoracic Surgeons (STS)
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology leader named CEO of Society of Thoracic Surgeons

Share on Twitter Share on Facebook Share on Linkedin
Justine Turco Incoming CEO/Executive Director Society of Thoracic Surgeons (STS)
Justine Varieur Turco held several leadership positions with the American College of Cardiology over the years. She is also a former Cardiovascular Business editor.
READ MORE >

Swallowed needle leads to serious heart damage—persistent care saves the day

The patient had a habit of holding sewing needles in his mouth while he worked as a tailor. He did not mention this at first, however, creating a challenge for his care team.

READ MORE >
Accidentally swallowing a sewing needle could have cost one 54-year-old patient his life. His care team was persistent, however, exploring his unexplained symptoms until they identified the problem.
Share on Twitter Share on Facebook Share on Linkedin

Swallowed needle leads to serious heart damage—persistent care saves the day

Share on Twitter Share on Facebook Share on Linkedin
Accidentally swallowing a sewing needle could have cost one 54-year-old patient his life. His care team was persistent, however, exploring his unexplained symptoms until they identified the problem.
The patient had a habit of holding sewing needles in his mouth while he worked as a tailor. He did not mention this at first, however, creating a challenge for his care team.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR for moderate aortic stenosis | BP drug recalled | Stroke prevention device fails | New Medicare cuts | CCTA-guided PCI
A new way to think about the heart health of women | GLP-1 drugs vs. metformin | Cannabis use may increase risk of CVD, stroke
New Medicare payment cuts | Telemedicine vs. in-person cardiology visits | FDA confirms Class I recall | Startup raises $160M
FDA approves transcatheter treatment for PVL | CCTA-guided PCI | Real-world RDN outcomes | J&J launches new IVL catheter
CCTA vs. IVUS for PCI guidance: Carlos Collet reviews the data | The real-world benefits of RDN | New TAVR tech falls short
TAVR Highlights: New data on treating moderate AS | CMS may expand coverage again | Is surgical backup still necessary?
GLP-1 drugs vs. metformin | BP drug recalled | The health risks of cannabis use | Energy drinks linked to heart issues
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup